3-BROMO-2-PIPERIDIN-1-YLPYRIDINE
![]() |
- $75 - $1171
- Product name: 3-BROMO-2-PIPERIDIN-1-YLPYRIDINE
- CAS: 1352318-07-0
- MF: C10H13BrN2
- MW: 241.13
- EINECS:
- MDL Number:MFCD20529522
- Synonyms:3-BROMO-2-PIPERIDIN-1-YLPYRIDINE;3-Bromo-2-piperidinopyridine, HCl;3-Bromo-2-(1-piperidinyl)pyridine;3-Bromo-2-piperidinopyridine Hydrochloride;3-bromo-2-(1-piperidinyl)-Pyridine, hydrochloride (1:1)
5 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 100mg
- 25g
- 100g
- ManufacturerAK Scientific
- Product numberZ9852
- Product description3-Bromo-2-piperidinopyridineHCl
- Packaging100g
- Price$1171
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM319897
- Product description3-Bromo-2-piperidinopyridine,HCl 95%
- Packaging25g
- Price$284
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11288903
- Product description3-Bromo-2-piperidinopyridine,HCl 95+%
- Packaging100g
- Price$790
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11288903
- Product description3-Bromo-2-piperidinopyridine,HCl 95+%
- Packaging25g
- Price$301
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB701493
- Product description3-Bromo-2-piperidinopyridineHydrochloride
- Packaging100mg
- Price$75
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | Z9852 | 3-Bromo-2-piperidinopyridineHCl | 100g | $1171 | 2021-12-16 | Buy |
Chemenu | CM319897 | 3-Bromo-2-piperidinopyridine,HCl 95% | 25g | $284 | 2021-12-16 | Buy |
Crysdot | CD11288903 | 3-Bromo-2-piperidinopyridine,HCl 95+% | 100g | $790 | 2021-12-16 | Buy |
Crysdot | CD11288903 | 3-Bromo-2-piperidinopyridine,HCl 95+% | 25g | $301 | 2021-12-16 | Buy |
TRC | B701493 | 3-Bromo-2-piperidinopyridineHydrochloride | 100mg | $75 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|